Presentation + Paper
8 March 2023 Classifying tumor heterogeneity of human esophageal cancer biopsies by dynamic contrast OCT with deep learning
Zhen Hua, Shadia Jalal, John Turek, David D. Nolte
Author Affiliations +
Abstract
Tumor heterogeneity is one of the greatest obstacles standing in the way of successful cancer therapy. Cancer in a single patient is not a single disease, but is a host of related diseases, all of which need to respond to a single treatment regimen. We have completed the first human clinical trial in esophageal cancer using dynamic-contrast OCT (DC-OCT) based on full-frame digital holography to assess the spatial heterogeneity of biopsy response to platinum-based chemotherapy. A deep twin neural network successfully identified biopsy sub-phenotypes in the dynamic tissue response that enabled accurate prediction of patient treatment success.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Zhen Hua, Shadia Jalal, John Turek, and David D. Nolte "Classifying tumor heterogeneity of human esophageal cancer biopsies by dynamic contrast OCT with deep learning", Proc. SPIE 12367, Optical Coherence Tomography and Coherence Domain Optical Methods in Biomedicine XXVII, 123670L (8 March 2023); https://doi.org/10.1117/12.2647602
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Biopsy

Cancer

Neural networks

Chemotherapy

Deep learning

Optical coherence tomography

Biological samples

RELATED CONTENT


Back to Top